SANUWAVE Health Q2 preliminary revenue $4.5-4.7M, 16%-21% YoY growth, in line with guidance

SANUWAVE Health, Inc.

2023-Q2 EPS reported -$0.04 revenue$8,450,000

Preliminary Q2 2023 revenue estimated at $4.5M to $4.7M, up 16%-21% vs Q2 2022.
CEO Morgan Frank says results consistent with guidance provided in Q1 2023 earnings release.
Production constraints mentioned as an ongoing challenge; full Q2 results expected mid-August.
Preliminary figures subject to adjustment upon completion of quarter-end close.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SANUWAVE Health, Inc. reported the second quarter ended June 30, 2023 results: revenue $4.5 million to $4.7 million.

Period: the second quarter ended June 30, 2023
Revenue: $4.5 million to $4.7 million
Result: preliminary results

Exact text from the filing

SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-035117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.